ShannonLeigh(Huggins)Huggins-PuhallaMD

PubMed

• Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive l...
  Puhalla S, Wilks S, Brufsky AM, O'Shaughnessy J, Schwartzberg LS, Berrak E, Song J, Vahdat L> ;Breast Cancer (Dove Med Press). 2016
• Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases.
  Priedigkeit N, Hartmaier RJ, Chen Y, Vareslija D, Basudan A, Watters RJ, Thomas R, Leone JP, Lucas PC, Bhargava R, Hamilton RL, Chmielecki J, Puhalla SL, Davidson NE, ...> ;JAMA Oncol. 2016 Dec 07
• A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: de...
  Isakoff SJ, Puhalla S, Domchek SM, Friedlander M, Kaufman B, Robson M, Telli ML, Dieras V, Han HS, Garber JE, Johnson EF, Maag D, Qin Q, Giranda VL, Shepherd SP> ;Future Oncol. 2016 Oct 14
• Detection of ESR1 mutations in circulating cell-free DNA from patients with metastatic breast cancer treated with palbociclib and letrozole.
  Gyanchandani R, Kota KJ, Jonnalagadda AR, Minteer T, Knapick BA, Oesterreich S, Brufsky AM, Lee AV, Puhalla SL> ;Oncotarget. 2016 Aug 19
• Risedronate may preserve bone microarchitecture in breast cancer survivors on aromatase inhibitors: A randomized, controlled clinical trial.
  Prasad C, Greenspan SL, Vujevich KT, Brufsky A, Lembersky BC, van Londen GJ, Jankowitz RC, Puhalla SL, Rastogi P, Perera S> ;Bone. 2016 Sep
• Breast cancer: The 21-gene recurrence score - biology remains at the forefront.
  Puhalla SL, Davidson NE> ;Nat Rev Clin Oncol. 2016 Aug
• Polymorphisms in DNA repair and oxidative stress genes associated with pre-treatment cognitive function in breast cancer survivors: an exploratory study.
  Koleck TA, Bender CM, Sereika SM, Brufsky AM, Lembersky BC, McAuliffe PF, Puhalla SL, Rastogi P, Conley YP> ;Springerplus. 2016
• Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast C...
  Freedman RA, Gelman RS, Wefel JS, Melisko ME, Hess KR, Connolly RM, Van Poznak CH, Niravath PA, Puhalla SL, Ibrahim N, Blackwell KL, Moy B, Herold C, Liu MC, Lowe A, A...> ;J Clin Oncol. 2016 Mar 20
• Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients.
  Wang P, Bahreini A, Gyanchandani R, Lucas PC, Hartmaier RJ, Watters RJ, Jonnalagadda AR, Trejo Bittar HE, Berg A, Hamilton RL, Kurland BF, Weiss KR, Mathew A, Leone JP...> ;Clin Cancer Res. 2016 Mar 01
• Characterizing Molecular Variants and Clinical Utilization of Next-generation Sequencing in Advanced Breast Cancer.
  Gurda GT, Ambros T, Nikiforova MN, Nikiforov YE, Lucas PC, Dabbs DJ, Lee AV, Brufsky AM, Puhalla SL, Bhargava R> ;Appl Immunohistochem Mol Morphol. 2016 Feb 09
• Metastatic breast cancer patients: attitudes toward tissue donation for rapid autopsy.
  Achkar T, Wilson J, Simon J, Rosenzweig M, Puhalla S> ;Breast Cancer Res Treat. 2016 Jan
• Impact of prior anthracycline or taxane use on eribulin effectiveness as first-line treatment for metastatic breast cancer: results from two phase 2, multicenter, sing...
  O'Shaughnessy J, McIntyre K, Schwartzberg L, Wilks S, Puhalla S, Berrak E, Song J, Vahdat L> ;Springerplus. 2015
• The molecular landscape of premenopausal breast cancer.
  Liao S, Hartmaier RJ, McGuire KP, Puhalla SL, Luthra S, Chandran UR, Ma T, Bhargava R, Modugno F, Davidson NE, Benz S, Lee AV, Tseng GC, Oesterreich S> ;Breast Cancer Res. 2015 Aug 07
• Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial.
  Greenspan SL, Vujevich KT, Brufsky A, Lembersky BC, van Londen GJ, Jankowitz RC, Puhalla SL, Rastogi P, Perera S> ;Osteoporos Int. 2015 Jun
• Unsanctifying the sanctuary: challenges and opportunities with brain metastases.
  Puhalla S, Elmquist W, Freyer D, Kleinberg L, Adkins C, Lockman P, McGregor J, Muldoon L, Nesbit G, Peereboom D, Smith Q, Walker S, Neuwelt E> ;Neuro Oncol. 2015 May
• RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway.
  Xie J, Kim H, Moreau LA, Puhalla S, Garber J, Al Abo M, Takeda S, D'Andrea AD> ;J Clin Invest. 2015 Apr
• Surgery for common bile duct stones--a lost surgical skill; still worthwhile in the minimally invasive century?
  Puhalla H, Flint N, O'Rourke N> ;Langenbecks Arch Surg. 2015 Jan
• Should we embrace or ablate our urge to (ovarian) suppress?
  Jankowitz RC, Puhalla S, Davidson NE> ;J Clin Oncol. 2014 Dec 10
• Phase 2, multicenter, single-arm study of eribulin mesylate with trastuzumab as first-line therapy for locally recurrent or metastatic HER2-positive breast cancer.
  Wilks S, Puhalla S, O'Shaughnessy J, Schwartzberg L, Berrak E, Song J, Cox D, Vahdat L> ;Clin Breast Cancer. 2014 Dec
• A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer.
  Zhao M, Pan X, Layman R, Lustberg MB, Mrozek E, Macrae ER, Wesolowski R, Carothers S, Puhalla S, Shapiro CL, Ramaswamy B> ;Invest New Drugs. 2014 Dec
• Management of breast cancer brain metastases is moving forward, but new options are still needed.
  Pahuja S, Puhalla S> ;Oncology (Williston Park). 2014 Jul
• TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.
  Anders C, Deal AM, Abramson V, Liu MC, Storniolo AM, Carpenter JT, Puhalla S, Nanda R, Melhem-Bertrandt A, Lin NU, Kelly Marcom P, Van Poznak C, Stearns V, Melisko M, ...> ;Breast Cancer Res Treat. 2014 Aug
• Introduction of an acute surgical unit: comparison of performance indicators and outcomes for operative management of acute appendicitis.
  Lancashire JF, Steele M, Parker D, Puhalla H> ;World J Surg. 2014 Aug
• Metastasis of breast carcinoma to the maxillary sinus.
  Leone JP, Bhattacharya S, Socinski MA, Sohnen A, Chiosea S, Puhalla S, Brufsky A> ;Breast J. 2014 May-Jun
• BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different.
  Burgess M, Puhalla S> ;Front Oncol. 2014
• Join now to see all